The synergistic ototoxicity of adalimumab combined with methotrexate in the treatment of ankylosing spondylitis.

Front Neurol · 2026 · PMC13102594 · PMID 42037676

Europe PMC DOI

hedged sentence

0.0730

closest p · 1.5× alpha

0.0730

boldest claim

The sentences

did not reach statistical significancep = 0.073so close (0.05 < p ≤ 0.1)

Furthermore, the hearing test results indicated that the proportion of baseline hearing abnormalities in the case group was higher than that in the control group; however, this difference did not reach statistical significance (χ 2 = 3.21, p = 0.073).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.